Aurora Cannabis Inc
NASDAQ:ACB
Aurora Cannabis Inc
NASDAQ:ACB
Price:
3.68
USD
4.25%
Market Cap:
$200.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Aurora Cannabis Inc
NASDAQ:ACB
|
CA |
|
Corby Spirit and Wine Ltd
TSX:CSW.A
|
CA |
|
B
|
Banco BTG Pactual SA
BOVESPA:BPAC3
|
BR |
|
Yijiahe Technology Co Ltd
SSE:603666
|
CN |
|
L
|
Lingkaran Trans Kota Holdings Bhd
KLSE:LITRAK
|
MY |
|
C
|
China Shineway Pharmaceutical Group Ltd
OTC:CSWYF
|
CN |
|
T
|
Toho Zinc Co Ltd
F:T62
|
JP |
|
C
|
CARGO Therapeutics Inc
NASDAQ:CRGX
|
US |
|
GN Store Nord A/S
OTC:GGNDF
|
DK |
|
Wisdomtree Inc
NYSE:WT
|
US |
|
I
|
Instadose Pharma Corp
OTC:INSD
|
US |
|
National Fertilizers Ltd
BSE:523630
|
IN |
|
PKSHA Technology Inc
TSE:3993
|
JP |
|
R
|
Rakuten Bank Ltd
TSE:5838
|
JP |
|
Namyang Dairy Products Co Ltd
KRX:003920
|
KR |
|
P
|
Pezm Gold Inc
XTSX:PEZM.H
|
CA |
|
Pharmacielo Ltd
XTSX:PCLO
|
CA |
|
Happy Valley Nutrition Ltd
ASX:HVM
|
NZ |
|
E
|
Escrow Agent Japan Inc
TSE:6093
|
JP |
|
Azarga Uranium Corp
TSX:AZZ
|
US |
|
A
|
Activation Group Holdings Ltd
HKEX:9919
|
CN |
|
E
|
Equity Development Investment Tbk PT
IDX:GSMF
|
ID |
|
Cluey Ltd
ASX:CLU
|
AU |
Multiples-Based Value
The
Multiples-Based Value for
Aurora Cannabis Inc (ACB)
under the Base Case is
hidden
USD.
Compared with the current market price of 3.68 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ACB Multiples-Based Value
LOCKED
Multiples Across Competitors
ACB Competitors Multiples
Aurora Cannabis Inc Competitors
Aurora Cannabis Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Aurora Cannabis Inc
NASDAQ:ACB
|
289.2m USD | 0.8 | -3.2 | -1.3 | -1.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 5.8 | 26.7 | 17.1 | 21.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP | 5.2 | 29.8 | 16.5 | 23.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF | 5 | 20.2 | 12.5 | 16.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.4 | 15.6 | 9.7 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.7 | 11.1 | 8.2 | 9.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.8B GBP | 2.6 | 15.1 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
